REVELATION BIOSCIENCES INC REVB

US Healthcare Pharmaceutical Preparations
$1.08
+3.8%
52w: $0.96 – $12.36

Latest 13F among current holders filed 1 month ago (May 15, 2026)

Price — last 12 months

research preview data
0.966.6612.36
Jun 20, 2025 Jul 2, 2026
Institutional holders
11
+10 QoQ
13F value
$600K
+163754.1% QoQ
Smart-money holders
0
signal tier ≥ 2
New smart buyers
0
Q1 2026

Institutional value by quarter

$29K
Q1 2024
$96K
Q2 2024
$84K
Q3 2024
$49K
Q4 2024
$954
Q1 2025
$0
Q2 2025
$366
Q4 2025
$600K
Q1 2026

Number of holders

8
Q1 2024
8
Q2 2024
8
Q3 2024
10
Q4 2024
2
Q1 2025
1
Q2 2025
1
Q4 2025
11
Q1 2026

Who owns REVB?

Q1 2026 filings
FundTypeSharesValue% of fundChange
ARMISTICE CAPITAL, LLC Quant stat arb323.2K$388K0.0%New
SABBY MANAGEMENT, LLC Other99.4K$119K2.1%New
GEODE CAPITAL MANAGEMENT, LLC Index provider43.2K$52K0.0%New
VANGUARD FIDUCIARY TRUST CO Diversified mechanical13.1K$16K0.0%
XTX Topco Ltd Market maker11.4K$14K0.0%New
UBS Group AG Bank broker4.1K$5K0.0%New
Tower Research Capital LLC (TRC) Market maker4.1K$5K0.0%New
ROYAL BANK OF CANADA Bank broker747$1K0.0%New
SBI Securities Co., Ltd. Diversified mechanical344$4130.0%-24.9%
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Bank broker9$110.0%New
Caitong International Asset Management Co., Ltd Diversified mechanical1$10.0%New

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.